Literature DB >> 16990151

Avian hepatitis E virus in an outbreak of hepatitis--splenomegaly syndrome and fatty liver haemorrhage syndrome in two flaxseed-fed layer flocks in Ontario.

A C Agunos1, D Yoo, S A Youssef, D Ran, B Binnington, D B Hunter.   

Abstract

Two commercial layer chicken flocks that were fed a flax-based diet beginning at 28 weeks of age for the production of omega-3 fatty-acid-enriched eggs experienced increased mortality when the birds reached 37 weeks. The average weekly mortality was 0.34% over a 20-week period, with peak mortality of 0.9% for 1 week. Reduced feed consumption, reduced body weight gain and poor peak production were noticed prior to the onset of increased mortality. A total of 245 birds were necropsied and 78% of these had lesions in the liver and spleen, with 44% of those necropsied having changes consistent with hepatitis-splenomegaly syndrome, with lesions ranging from acute periportal lymphoplasmacytic hepatitis to chronic severe cholangiohepatitis with haemorrhage, vasculitis and amyloidosis. A total of 11% of the birds had lesions typical of fatty liver haemorrhagic syndrome, and 22% had lesions found in both hepatitis-splenomegaly syndrome and fatty liver haemorrhagic syndrome. No significant bacteria or viruses were recovered from samples of the liver/bile or spleen but 11 of 21 bile samples contained avian hepatitis E virus RNA detectable with a reverse transcriptase-polymerase chain reaction assay. Comparative sequence analysis found identities of 82 to 92% and 78 to 80% between the helicase and capsid protein genes, respectively, of the virus detected in this outbreak and those of other avian hepatitis E virus isolates, suggesting extensive genetic heterogeneity in avian hepatitis E viruses in Ontario flocks.

Entities:  

Mesh:

Year:  2006        PMID: 16990151     DOI: 10.1080/03079450600920976

Source DB:  PubMed          Journal:  Avian Pathol        ISSN: 0307-9457            Impact factor:   3.378


  7 in total

1.  Comparative pathogenesis in specific-pathogen-free chickens of two strains of avian hepatitis E virus recovered from a chicken with Hepatitis-Splenomegaly syndrome and from a clinically healthy chicken.

Authors:  P Billam; T LeRoith; R S Pudupakam; F W Pierson; R B Duncan; X J Meng
Journal:  Vet Microbiol       Date:  2009-06-11       Impact factor: 3.293

2.  Construction of an infectious cDNA clone of avian hepatitis E virus (avian HEV) recovered from a clinically healthy chicken in the United States and characterization of its pathogenicity in specific-pathogen-free chickens.

Authors:  Hyuk Moo Kwon; Tanya LeRoith; R S Pudupakam; F William Pierson; Yao-Wei Huang; Barbara A Dryman; Xiang-Jin Meng
Journal:  Vet Microbiol       Date:  2010-07-22       Impact factor: 3.293

3.  Serological prevalence, genetic identification, and characterization of the first strains of avian hepatitis E virus from chickens in Korea.

Authors:  Hyuk Moo Kwon; Haan Woo Sung; Xiang-Jin Meng
Journal:  Virus Genes       Date:  2012-05-26       Impact factor: 2.332

4.  Seroprevalence and risk factors associated with hepatitis E virus infection in three species of pet birds in northwest China.

Authors:  Wei Cong; Qing-Feng Meng; Xiao-Feng Shan; Wu-Wen Sun; Si-Yuan Qin; Xiao-Xuan Zhang; Si-Yang Huang; Ai-Dong Qian
Journal:  ScientificWorldJournal       Date:  2014-10-30

Review 5.  Avian Hepatitis E Virus: With the Trend of Genotypes and Host Expansion.

Authors:  Peng Sun; Shaoli Lin; Shenghu He; En-Min Zhou; Qin Zhao
Journal:  Front Microbiol       Date:  2019-07-24       Impact factor: 5.640

Review 6.  Hepatitis E: A disease of reemerging importance.

Authors:  Siddharth Sridhar; Susanna K P Lau; Patrick C Y Woo
Journal:  J Formos Med Assoc       Date:  2015-03-12       Impact factor: 3.282

7.  Effect of housing arrangement on fecal-oral transmission of avian hepatitis E virus in chicken flocks.

Authors:  Baoyuan Liu; Yani Sun; Yiyang Chen; Taofeng Du; Yuchen Nan; Xinjie Wang; Huixia Li; Baicheng Huang; Gaiping Zhang; En-Min Zhou; Qin Zhao
Journal:  BMC Vet Res       Date:  2017-09-07       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.